Johnson & Johnson’s subcutaneous Tremfya holds potential to set new standard in Crohn’s disease…
Tremfya's subcutaneous formulation may offer new flexibility for Crohn's disease treatment, positioning it as a key contender in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Crohn’s disease (CD)
Novel therapies to drive Crohn’s disease market growth across 8MM to $15 bn by 2032: GlobalData
An anticipated 11 assets in the late-stage pipeline will enter the CD market during the forecast period